Smoothing the mosaic subclinical melanoderma by calcipotriol.

Administration, Topical; Calcitriol/administration & dosage/analogs & derivatives/therapeutic use; Dermatologic Agents/administration & dosage/therapeutic use; Double-Blind Method; Facial Dermatoses/diagnosis/drug therapy; Humans; Image Processing, Computer-Assisted; Male; Melanosis/diagnosis/drug therapy; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Ultraviolet Rays/adverse effects

Abstract :

[en] BACKGROUND: The observation of photo-exposed skin under ultraviolet light reveals a mosaic pattern of varying intensity in epidermal melanization. Several patterns of mosaic subclinical melanoderma (MSM) have been described using a specially designed CCD camera and the ultraviolet light-enhanced visualization (ULEV) method. Vitamin D(3) and its analogues influence the biology of keratinocytes and melanocytes. OBJECTIVE: To assess the effect of calcipotriol on MSM. METHODS: This randomized split-face study was conducted in 27 men to compare the effect of once daily applications of 5% calcipotriol cream or a moisturizing cream on the heterogeneity of facial MSM. Computerized image analysis of video images was used at 1-month intervals before and during a 2-month treatment, as well as during a 3-month follow-up. RESULTS: At both sites, the average melanin content of the epidermis showed no significant change over time. However, the mottled appearance was smoothened at the calcipotriol site, whereas it was increased at the site receiving the moisturizer. CONCLUSION: The decreased heterogeneity in MSM after calcipotriol applications suggests a control of the epidermal melanocyte unit by the vitamin D(3) derivative.

Disciplines :

Dermatology

Author, co-author :

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Smoothing the mosaic subclinical melanoderma by calcipotriol.

Publication date :

2007

Journal title :

Journal of the European Academy of Dermatology and Venereology

ISSN :

0926-9959

eISSN :

1468-3083

Publisher :

Blackwell Publishing, Oxford, United Kingdom

Volume :

Issue :

Pages :

657-61

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 05 February 2009

Statistics

Number of views

47 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Hermanns JF, Petit L, Piérard-Franchimont C, Cauwenbergh G, Piérard GE. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: Effect of depigmenting agents. Dermatology 2000; 202: 118-122.
Petit L, Piérard-Franchimont C, Saint Léger D, Loussouarn G, Piérard GE. Subclinical speckled perifollicular melanosis of the scalp. Eur J Dermatol 2002; 12: 565-568.
Hermanns JF, Petit L, Piérard-Franchimont C, Paquet P, Piérard GE. Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology 2002; 204: 281-286.
Petit L, Fogouang L, Uhoda I et al. Regional variability in mottled photo-induced melanoderma in the elderly. Exp Gerontol 2003; 38: 327-331.
Quatresooz P, Petit L, Uhoda I, Piérard-Franchimont C, Piérard GE. Mosaic subclinical melanoderma. An Achilles heel for UV-related epidermal cancerogenesis? Int J Oncol 2004; 25: 763-768.
Uhoda E, Piérard-Franchimont C, Petit L, Piérard GE. The conundrum of skin pores in dermocosmetology. Dermatology 2005; 210: 3-7.
Xhauflaire-Uhoda E, Hermanns JF, Piérard-Franchimont C, Piérard GE. Highlighting the rim of perifollicular epidermal unit. Eur J Dermatol 2006; 16: 225-229.
Fogh K, Kragballe K. Vitamine D3 analogues. Dermatol Ther 1999; 11: 20-31.
Ortonne JP, Humbert P, Nicolas JF et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 μg g-1 ointment and calcipotriol 50 μg g-1 ointment on chronic plaque psorasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003; 148: 326-333.
Uhoda I, Quatresooz P, Hermanns-Lê T et al. Histometric assessment of psoriatic plaques treated by vitamin D3 derivatives. Dermatology 2003; 206: 366-369.
Colston K, Colston MJ, Feldman D. 1,25-Dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108: 1083-1086.
Frampton RJ, Omond SA, Eisman JA. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 1983; 43: 4443-4447.
Eisman JA, Barkla DH, Tutton PJ. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987; 47: 21-25.
Ranson M, Posen S, Masson RS. Human melanocytes as a target tissue for hormones; in vitro studies with 1α25,dihydroxyvitamin D3 and α-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 1988; 91: 593-598.
Evans SR, Houghton AM, Schumaker L et al. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res 1996; 61: 127-133.
Sauer B, Ruwick L, Kleuser B. Antiapoptotic action of 1α25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res 2003; 13: 339-347.
Virador VM, Muller J, Wu X et al. Influence of α-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes. FASEB J 2002; 16: 105-107.
Kvam E, Tyrrel RM. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol 1999; 113: 209-213.
Bykov VJ, Marcusson JA, Hemminki K. Protective effects of tanning on cutaneous DNA damage in situ. Dermatology 2001; 202: 22-26.
Danielsson C, Fehsel K, Polly P, Carlberg C. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues. Cell Death Differ 1998; 5: 946-952.
Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16: 83-95.
Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-459.
Baker AR, McDonnell DP, Hughes M et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85: 3294-3298.
Jimenez-Lara AM, Aranda A. Interaction of vitamin D and retinoid receptors on regulation of gene expression. Horm Res 2000; 54: 301-305.
Boehm N, Samama B, Cribier B, Rochette Egly C. Retinoic-acid receptor β expression in melanocytes. Eur J Dermatol 2004; 14: 19-23.
Hutchinson PE, Osborne JE, Lear JT et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 6: 498-504.
Haddad MM, Xu W, Medrano EE. Aging in epidermal melanocytes: Cell cycle genes and melanins. J Investig Dermatol Symp Proc 1998; 3: 36-40.
Takema Y, Yorimoto Y, Ohsu H, Osanai O, Kawai M. Age-related discontinuous changes in the in vivo fluorescence of human facial skin. J Dermatol Sci 1997; 15: 55-58.
Leffell DJ, Stetz ML, Milstone LM, Deckelbaum LI. In vivo fluorescence of human skin: A potential marker of photoaging. Arch Dermatol 1999; 124: 1514-1518.
Fetil E, Ilknur T, Altiner A et al. Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. J Dermatol 2005; 32: 868-874.